ConductScience.org, home

Trial · NCT03018249

Adverse events58

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnemiaBlood and lymphatic system disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA323
otherAnemiaBlood and lymphatic system disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat323
otherAbdominal PainGastrointestinal disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA423
otherAbdominal PainGastrointestinal disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat823
otherConstipationGastrointestinal disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA523
otherConstipationGastrointestinal disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat423
otherDiarrheaGastrointestinal disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA223
otherDiarrheaGastrointestinal disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat423
otherDry MouthGastrointestinal disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA123
otherDry MouthGastrointestinal disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat223
otherNauseaGastrointestinal disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA223
otherNauseaGastrointestinal disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat423
otherEdema LimbsGeneral disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA323
otherEdema LimbsGeneral disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat223
otherFatigueGeneral disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA423
otherFatigueGeneral disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat823
otherInjection Site ReactionGeneral disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA423
otherInjection Site ReactionGeneral disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat523
otherPainGeneral disordersArm I (Medroxyprogesterone Acetate, Hysterectomy) MPA423
otherPainGeneral disordersArm II (Medroxyprogesterone Acetate, Entinostat, Hysterectomy) MPA and Entinostat423

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03018249/events